© 2020 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.
However, serious kidney problems and bone fractures were rare among people taking either Descovy or Truvada for HIV prevention.
However, a recent study found that this varied based on the specific integrase inhibitor used.
Sci-B-Vac may offer more protection for older people and those with a weaker immune system.
This finding from a study of people switching from TDF to TAF for HIV treatment may also have implications for those on PrEP.
Users of the social media app had a higher rate of some sexually transmitted infections but a lower rate of HIV.
The drug can quickly reverse opioid-driven overdoses.
As long-acting injectables near approval, daily pill versions of the same drugs show long-term benefit.
An analysis of 15,000 insured people with HIV also confirmed past findings that single-tablet regimens are associated with higher adherence.
People who received the vaccine did, however, show stronger immune responses against the virus.
Surveys reveal difficulties associated with daily pills and a desire for long-acting injectable therapy.
Researchers at George Washington University take a look.
Expanded access study confirms the long-acting monoclonal antibody works well in people with extensive prior treatment.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.
